Botanical Extracts and Adaptogens
The following table details common plant-based nootropics, focusing on their chemical standardization and biological mechanisms.
| Ingredient | Primary Active Compounds | Mechanism of Action | Common Standardization |
|---|---|---|---|
| Bacopa Monnieri | Bacosides (A and B) | Promotes synaptic communication and antioxidant enzyme activity in the hippocampus (NIH). | 20% to 50% Bacosides (NIH). |
| Rhodiola Rosea | Rosavins and Salidrosides | Modulates the HPA axis and inhibits monoamine oxidase (MAO) (Integrative Therapeutics). | 3% Rosavins and 1% Salidrosides (Integrative Therapeutics). |
| Ginkgo Biloba | Flavone glycosides and Terpene lactones | Increases cerebral blood flow and acts as a free radical scavenger (PubMed). | 24% Flavone glycosides and 6% Terpene lactones (PubMed). |
| Lion's Mane | Hericenones and Erinacines | Stimulates Nerve Growth Factor (NGF) synthesis; compounds vary by plant part (Mycogenius). | Varies; Hericenones (fruiting body), Erinacines (mycelium) (Mycogenius). |
| Panax Ginseng | Ginsenosides (e.g., Rb1, Rg1) | Acts as an adaptogen to modulate immune and psychological stress responses (AAFP). | 4% to 7% Ginsenosides (AAFP). |
| L-Theanine | γ-glutamylethylamide | Partial co-agonist at NMDA receptors; increases GABA and serotonin levels (PubMed). | Typically 98%+ pure amino acid. |
Cholinergics and Metabolic Compounds
This section covers compounds involved in neurotransmitter synthesis and cellular energy metabolism within the brain.
| Ingredient | Primary Active Compounds | Mechanism of Action | Composition Fact |
|---|---|---|---|
| Alpha-GPC | L-Alpha glycerylphosphorylcholine | Rapidly increases acetylcholine levels and supports cell membrane integrity (NeuroVesa). | Contains approximately 40% choline by weight (NeuroVesa). |
| Citicoline | Cytidine 5'-diphosphocholine | Precursor to phosphatidylcholine; supports the Kennedy pathway for membrane synthesis (NeuroVesa). | Contains approximately 18% choline by weight (NeuroVesa). |
| Caffeine | 1,3,7-trimethylxanthine | Antagonizes adenosine receptors to prevent the onset of drowsiness (FDA). | Mean half-life is approximately 5 hours in healthy adults (NCBI). |
| Creatine | Methylguanidine-acetic acid | Regenerates Adenosine Triphosphate (ATP) via the phosphocreatine system (NIH). | Monohydrate is the most studied form for brain energetics (NIH). |
| Phosphatidylserine | Glycerophospholipid | Essential component of neuronal membranes; involved in cell-to-cell signaling (FDA). | FDA allows qualified health claims for cognitive dysfunction (FDA). |
Last verified: 2026-06-29
Sources
- Bacopa monnieri: Preclinical and Clinical Evidence - PMC
- The Quirky Dosing of Rhodiola - Integrative Therapeutics
- EGb 761: Ginkgo biloba extract - PubMed
- Hericenones and Erinacines Explained - Mycogenius
- Panax Ginseng - American Family Physician
- Characterization of L-Theanine Excitatory Actions - PubMed
- Alpha-GPC vs. Citicoline: Choline Content - NeuroVesa
- Spilling the Beans: How Much Caffeine is Too Much? - FDA
- Pharmacology of Caffeine - NCBI
- Effects of Creatine Supplementation on Brain Function - NIH
- Qualified Health Claims: Phosphatidylserine - FDA